Podcasts about molecular

Elo Life Systems: https://elolife.com/Super excited to bring on Matt DiLeo of ELO Life Systems on today's episode. Some of you may remember that ELO Life CEO Todd Rands was a part of 412 of this podcast two years ago. I've been fascinated by their work ever since to bring to the market what they call molecular farming. Matt does a great job of explaining the concept and how this shifts the value in some ways from food processors back to the farm by allowing farmers to grow desirable healthy ingredients inside of the commodity crops they already grow. It's kinda mind blowing. Some background on Matt: Dr. Matt DiLeo serves as the vice president of research & development at Elo Life Systems. In his role, Matt applies agricultural OMICs and precision breeding technologies to advance Elo's product pipeline. Prior to joining Elo, Matt held scientific leadership roles at Novozymes and KeyGene USA. Matt received his Ph.D. in Plant Pathology from UC Davis and completed a postdoc at the Boyce Thompson Institute, where he studied the impact of silencing regulatory genes on the nutritional composition of the tomato fruit metabolome.Matt seems to have a knack for being on the cutting edge of ag science and technology and has shown this in a variety of areas throughout his career.

Ross Halls is joined by Stuart Watson and Alex Jones to discuss Ipswich Town's search for a new manager.The boys discuss Gary O'Neil, who is set to be named the next Blues' boss following Kieran McKenna's departure.There's chat about his expected appointment, including his tactics, fan reaction, and his first tasks to tackle in the role.Then Stu gets his chance to discuss the 2026/27 Premier League fixtures, including August's opener at home to Sunderland and the run-in.There's also chat about the summer heatwave, while AJ discusses his experience watching Gorillaz over the weekend.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Bosma arhinia microphthalmia syndrome (BAMS) is a rare genetic disorder resulting in babies born without a nose, along with eye and reproductive anomalies. Our guests today investigated the developmental basis of this distinct defect using induced pluripotent stem cells (iPSCs) derived from patients with BAMS. They assessed the differentiation potential of BAMS patient-derived iPSCs into cranial placode cells, a group of progenitor cells that contribute to the formation of the nasal epithelium. This allowed them to study the behavior of the nasal epithelial cells during early development. Their work uncovered cellular mechanisms underlying BAMS and provided new insights into the developmental processes that shape the human nose. GuestsShifeng Xue is an Assistant Professor in the Department of Biological Sciences at the National University of Singapore (NUS). She received her Ph.D. in developmental biology from the University of California, San Francisco, where she trained with Maria Barna, and then completed her postdoctoral research at the Institute of Molecular and Cell Biology, A*STAR, Singapore. She is the recipient of the 2018 Young Scientist Award of the Singapore National Academy of Science.  Vanitha Venkoba Rao worked as a Research Fellow at NUS from 2020 to 2025. She earned her Ph.D. in Biochemistry and Molecular Biology from NUS and subsequently held research positions at inStem and Pandorum Technologies in India, before joining the Xue lab.HostJanet Rossant, Editor-in-Chief, Stem Cell Reports Supporting DocumentCranial placode differentiation defect in individuals born without a nose, Stem Cell Reports, 2026About Stem Cell ReportsStem Cell Reports is the open access, peer-reviewed journal of the International Society for Stem Cell Research (ISSCR) for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians. X: @StemCellReportsAbout ISSCRAcross more than 80 countries, the International Society for Stem Cell Research (@ISSCR) is the preeminent global, cross-disciplinary, science-based organization dedicated to advancing stem cell research and its translation to medicine.ISSCR StaffKeith Alm, Shuangshuang Du, Kym Kilbourne, Megan Koch, Jack Mosher, and Hunter Reed

Ross Halls caught up with former Ipswich Town forward David Lowe to discuss his time at Portman Road and journey in football in our Kings of Anglia podcast special.David spoke about a range of memories, including his early days in football, making his name at Wigan Athletic, scoring at Wembley and joining Ipswich.He chats about his relationship with John Duncan, debut season, trademark shuffle, favourite strike partners, ACL injury and overall time in Suffolk.The duo also discuss his journey in coaching, his spell as caretaker manager at Blackburn Rovers and what the future holds.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Alex Jones for the latest Kings of Anglia Ipswich Town podcast.The boys break down the 2026/27 Premier League fixtures, with Town kicking off the campaign at home to Sunderland before travelling to Man United.When are the key games? Are there any tough runs or unique quirks to look out for? Ross and AJ share their thoughts on what's to come, with the Blues aiming to survive in the top flight.Then it's onto pre-season, the plans in place and the friendlies scheduled for July and August as the players return to match action.There's also chat around the manager search, with Gary O'Neil and Ole Gunnar Solskjaer in the race to take over from Kieran McKenna.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Molecular hydrogen improves your body's antioxidant defenses instead of directly lowering oxidative stress, helping you recover without blocking muscle adaptation Molecular hydrogen helps you maintain speed and power during repeated sprints, especially in the final, fatigue-heavy stages where performance normally declines Hydrogen supports your cellular energy systems by improving mitochondrial function, allowing your muscles to maintain power under stress Unlike traditional antioxidants, hydrogen targets only the most damaging molecules, preserving the signals your body relies on to build strength and endurance Using hydrogen in short, repeated doses, especially through hydrogen-rich water, strengthens your body's resilience and speeds recovery over time

Ross Halls is joined by Alex Jones for the latest episode of Ipswich Town Transfer Talk.The boys start with the latest news on the Blues' manager search, with what looks to be like a two-horse race to replace Kieran McKenna at Portman Road.There's talk about the best fit, with possible pros and cons, before moving onto the latest transfer links.That includes a highly-rated La Liga striker and a newly-capped Italian no.9, plus chat around Nick Pope and a potential move for another shot-stopper.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Alex Jones is joined by football finance expert Kieran Maguire for another KOA exclusive interview following Ipswich Town's return to the Premier League.There's talk around the true value of promotion in 2026 before addressing the elephant in the room - the new financial rules that will impact the Blues and their top-flight foes.Then it's onto the summer transfer window. How much will Town look to spend, and just how important will foreign recruitment me?There's also chat about the importance of survival as Ipswich aim to establish themselves in the top flight.NOTE: This podcast was recorded before Kieran McKenna's departure was confirmed.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Welcome back to the Jack Westin MCAT Podcast with Mike and Molly! Last episode we tackled gels, SDS-PAGE and Western blots. Now we move into one of the most high-yield experimental technique topics on the MCAT: chromatography.If you have ever seen a chromatography question in a passage and had no idea where to start, this episode gives you a framework that works for every single type. No memorizing, just understanding.Get started with our resources!

In this solo episode, David Brühlmann explores the evolving landscape of biologic manufacturing platforms beyond CHO (Chinese hamster ovary) cells. Drawing from previous interviews with platform pioneers and rigorous data analysis, David examines where established and emerging hosts find their strengths—and their limits—in today's biomanufacturing environment.Topics DiscussedThe historical dominance of CHO cells and what's changed in the last decade (00:08)Three critical areas where alternative hosts might outperform CHO: cost, speed, and intrinsic product quality (04:52)Moss as a production platform: regulatory advantages, glycosylation, and oncology antibodies (05:47)Microalgae's carbon-negative potential and the current 1000-fold yield challenge (08:28)Molecular farming (plant-based production): timelines, case of the Medicago COVID-19 vaccine, and overcoming political—not technical—barriers (10:41)Silkworm-based production: infrastructure cost, individual variability, and progress in vaccines (13:07)Cyanobacteria: promise of photosynthetic biomanufacturing and current limitations for clinical use (15:06)The pattern emerging among all alternative platforms: finding niche advantages rather than universally replacing CHO (18:25)A framework for evaluating novel hosts moving forward (19:14)Part 2 examines whether “Will it replace CHO?” is the right question to be asking at all, and introduces an alternative framework for evaluating the issue more effectively.Smart insight:None of the “novel hosts” are universal CHO replacements. Winners emerge in narrow niches: plant farming for pandemic-scale vaccines, silkworms in veterinary and oral applications, and cyanobacteria as a long-term bet for sustainable production.Here are the episodes referenced:Episodes 163 - 164: How Moss Enables Production of Unproducible Protein Therapeutics with Andreas SchaafEpisodes 141 - 142: How Microalgae Cuts Antibody Costs by 70% and Redefines Biomanufacturing with Muriel BardorEpisodes 235 - 236: Plant-Based Biomanufacturing: How Molecular Farming Produces Biopharmaceuticals in Weeks, Not Months with Waranyoo PhoolcharoenEpisodes 217 - 218: Silkworm Biomanufacturing: From Ancient Silk Production to Phase I Vaccine Trials with Masafumi OsawaEpisodes 229 - 230: Cyanobacteria Biomanufacturing: Achieving Carbon-Neutral Production at Lower Cost Than Fermentation with Tim CorcoranNext:If you enjoyed this episode, please leave a review on Apple Podcasts or your favorite podcast platform. By doing so, we can empower more scientists like you. Stay tuned for more inspiring biotech insights in our next episode.Support the show

Check out the next episode of our podcast, Under the Surface. In episode 16, When Proteins Move: Woody Sherman on Computational Chemistry, Molecular Simulation, and the Future of AI in Drug Discovery, we chat with Woody Sherman, Founder and Chief Innovation Officer at PsiThera, and a longtime leader in computational chemistry, about how he went from studying quantum polymers to shaping modern tools like Induced Fit Docking.  Woody shares the moment that pulled him into protein simulations, his early exposure to AI at MIT, and how an internship at Biogen set him on the path to industry. He also reflects on his years at Schrödinger, building solutions, writing code, and learning how to solve real problems for scientists. Topics: How application scientists help connect research with real-world industry needs Woody's journey from university research to starting Silicon Therapeutics How tools like induced fit docking were created How drug discovery platforms have changed over time What's different between working in industry and in academia What's next for open molecular software and AI working together (02:05) Why mentorship matters for scientists (04:15) Woody's path through school and research (09:10) Shifting into custom molecular simulations (12:00) Going from the academic world to industry (15:00) Creating new tools for drug discovery at Schrodinger (22:10) Putting together a team of experts (26:15) Working together on drug design platforms (34:00) Leading application science teams around the world (41:45) Starting up Silicon Therapeutics (45:58) Progress in the development of the STING agonist medicine (49:00) Launching PsiThera (56:30) Focusing on inflammation and the immune system (60:15) Sharing science and data openly (69:00) How AI will shape the future of drug discovery (80:30) What Woody enjoys outside of work (82:20) Final thoughts and getting involved with the community Listener discretion is advised.  

Dr. Michael Park shares stories from a Proof-of-Concept study that combined lumbar or lumbosacral decompression and fusion surgery and neuromodulation. Dr. Park is a former principal investigator of the SynerFuse® proof-of-concept clinical trial and primary inventor of SynerFuse® technology. Dr. Park is a board-certified neurosurgeon, an associate professor, MnDRIVE neuromodulation scholar, William P. Van Wagenen Fellow, and director of stereotactic and functional neurosurgery in the Department of Neurosurgery and Neurology at the University of Minnesota. He has extensive experience with neuromodulation – deep brain stimulation. This surgical therapy for brain conditions such as Parkinson's disease, essential tremor, and dystonia modulates brain activity to treat symptoms. He also uses neuromodulation such as spinal cord stimulation and intrathecal drug delivery to treat cancer pain and chronic pain. In addition, working with epilepsy specialists, Dr. Park performs procedures such as surgical placement of depth and grid electrodes in the brain to identify abnormal epileptic brain areas and offer treatments which include resection, response neural stimulator (NeuroPace) placement, laser ablation, and vagal nerve stimulation. If patients are unable to have surgery, Dr. Park is able to treat some of the conditions using Gamma Knife radiosurgery as well. Dr. Park received his dual Bachelor of Arts and Sciences in economics and electrical engineering from Cornell University and a Bachelor of Arts in biology from the University of Kansas. He holds an M.D. and Ph.D. from the School of Medicine and Graduate Studies, Department of Molecular and Integrative Physiology, at the University of Kansas. He completed his neurosurgery residency at the Rhode Island Hospital/Brown University. He was awarded the prestigious William P. Van Wagenen Fellowship from the American Association of Neurological Surgeons and completed his fellowship with Dr. Jean Régis at the Université de la Méditerranée Aix-Marseille II, Assistance Publique L'Hôpital d'Adulte de la Timone in Marseille, France, in 2010. He was an Assistant Professor and the Director of Functional Neurosurgery and Pain in the Department of Neurosurgery at University of Louisville until 2014. Resources: Integrating Dorsal Root Ganglion Stimulation with Transforaminal Lumbar Interbody Fusion: Proof of Concept Study SynerFuse University of Minnesota Sponsor The Cox 8 Table by Haven Medical

Ross Halls is joined by Stuart Watson to discuss the Ipswich Town 2025/26 retained list.The duo start with the news that Wes Burns is in negotiations with the club over a new deal, as is veteran third-choice keeper David Button.They also chat about the release of Conor Chaplin and Conor Townsend, before looking ahead to what the future holds for Harry Clarke and Cameron Humphreys, who have had their contract options exercised for a further 12 months.Then it's onto the returning loanees and a big summer ahead for the club.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls caught up with former Ipswich Town forward Frank Nouble to discuss his time at Portman Road and journey in football in our Kings of Anglia podcast special.Frank spoke about a range of memories, including his early days in football, turning down a contract at Chelsea, playing in the Premier League with West Ham and joining Ipswich.He chats about his relationship with Mick McCarthy, his goals against Crystal Palace, meaning behind CLACK, and overall time in Suffolk.The duo also discuss his tag as a journeyman, playing in China and ambitions in coaching.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls and Alex Jones are back with the latest episode of Ipswich Town Transfer Talk after a hectic week.The boys looks at links to experienced duo Nick Pope and Callum Wilson, assessing whether they are the right profiles to make the move to Portman Road this summer.Then it's onto some different names - Paris FC star Ilan Kebbal has is another reported target, while dubious rumours surrounding Henrik Falchener and Fisnik Asllani are mentioned as well.There's also some chat around left-field candidates to replace Kieran McKenna, who stepped down from his role as Blues boss earlier this week.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Stuart Watson to discuss potential candidates to replace Kieran McKenna as Ipswich Town manager.The duo first look at Ole Gunnar Solskjaer, who is a former Manchester United colleague and close friend of the Northern Irishman, before looking at the early booking favourties in Gary O'Neil and Liam RoseniorThey also chat about Brendan Rodgers, Sean Dyche, Anthony Barry, Ange Postecoglou and more....Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Mark Heath is joined by Stuart Watson, Alex Jones and Ross Halls to give our live reaction to news that Kieran McKenna has walked away from Ipswich Town.We discuss the shock news, the manner of his departure, and discuss if this is actually the best way possible for him to leave.Then, of course, it's onto who might be next in the hot seat - we toss around a bunch of names, get plenty of suggestions from viewers and ponder the pros and the cons of each.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Episode: 3380 What underlies a term from physics: Ergodic (or Ergodicity).  Today, let us steal a word from physics.

Discover 5 key autoimmune triggers hiding in your past. From COVID and herpes simplex to staph, Epstein-Barr, and strep infections, Nurse Doza breaks down how past infections can reprogram your immune system to attack your own tissue — and what gut health has to do with it all. Gut (L-Glutamine) by MSW Nutrition Gut, featuring 4 grams of pure L-Glutamine per scoop, is the primary fuel source for the cells that line your intestinal wall. When past infections, antibiotics, or chronic stress compromise your gut barrier, your immune system loses its most important line of defense — creating the conditions where autoimmune triggers thrive. Gut helps repair the gut lining, reduce digestive inflammation, and support the immune cells that depend on a healthy gut to function properly. Whether you're managing an existing autoimmune disorder or working to prevent one, healing your gut is where it starts.

Ross Halls caught up with former Ipswich Town loanee Jack Colback to discuss his time at Portman Road and journey in football in our Kings of Anglia podcast special.Recently-retired Jack spoke about a range of memories, including his early days in football, starting out at Sunderland and joining Ipswich for two loan spells.He chats about playing under Roy Keane, his first season in senior football, goal of the season award, rooming with Pablo Counago and overall time in Suffolk.The duo also discuss his career as a whole and what's next after retiring from professional football.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Alex Jones to break down the latest Ipswich Town transfer news.The boys reflect on the latest links surrounding Kieran McKenna and the vacancy at Fulham before diving into some juicy transfer news surrounding Everton's Tim Iroegbunam.There's speculative discussion about ex-Blue Liam Delap, who could be leaving Chelsea, while teams ramp up interest in former Town target Hayden Hackney.There's also chat around academy transfers and a closer look at how Ipswich's recruitment strategy might work.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

The current Ebola outbreak in the Democratic Republic of the Congo and neighboring Uganda is caused by the Bundibugyo virus. There's no specific treatment or vaccine for this strain, unlike the more common Zaire strain that caused the 2014 outbreak.  Molecular biologist Christian Happi has dedicated his career to improving genomic sequencing capabilities and virus monitoring across the continent of Africa. He joins Flora to discuss the challenges of the current outbreak and his vision for better disease surveillance.  Guest: Dr. Christian Happi is a distinguished professor at Redeemer's University and runs the Institute of Genomics and Global Health in Nigeria. Other episodes you may enjoy: Inside the Nebraska quarantine facility responding to hantavirus Can ‘Suggestion-Box Science' Make Public Health More Useful? Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Mark Heath is back with Alex Jones and Stuart Watson to discuss all things Ipswich Town on the latest Kings of Anglia podcast.We kick off with the retained list - or lack of it - before moving onto the big talking point of the week, Kieran McKenna being linked to the Fulham job.We thrash out various scenarios and offer scores out of ten for level of concern. Then it's onto Aro Muric's departure and whether Christian Walton should be the Premier League starter, plus the latest sexy stuff transfer links.We finish with Mark returning to his Jamie Vardy signing suggestion, and a look at Alex's chat with footy finance expert Kieran Maguire.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

In this podcast, experts Manmeet Ahluwalia, MD, MBA; and Ashley S. Margol, MD, MS; discuss targeted therapies for adult and pediatric low-grade gliomas, pediatric diffuse midline glioma, and adult glioblastoma.

Molecular biologist, gerontologist and Ultra Marathoner, Dr. Bill Andrews, a pioneer in telomere and telomerase research, sits down with Kelly and makes the case that telomere shortening is the most important clock driving human aging for healthy people and that real “rejuvenation” has to show up in function, not just numbers on a lab report. His blunt standard is the “Betty White test”: can you clearly tell which version of someone is younger by how they look, feel, and behave? From there, we get practical for masters swimmers and endurance athletes. Bill breaks down the tug of war between telomere shortening and lengthening, why inflammation and oxidative stress speed up biological aging, and how training falls into a Goldilocks zone. Consistent movement can build immune tolerance, while sporadic extreme efforts can trigger unnecessary inflammation. We also cover stress reduction through yoga and meditation, and why tapering is a secret weapon for performance and recovery. We also take on the risky side of the longevity marketplace: misleading telomere tests in blood, “anti-aging” tactics that can increase cell turnover, and the hype cycle around peptides, stem cells, and exosomes. Bill explains how he evaluates evidence with critical meta-analysis, shares what he's seen from telomerase-activating ingredients, and points to tools like the ALCAT food sensitivity test and biological age testing to guide smarter choices. • telomeres as chromosome end caps and why they shorten with each cell division• telomerase as the enzyme that can rebuild telomeres and the “tug of war” model• inflammation and oxidative stress as drivers of accelerated aging• endurance exercise as a Goldilocks effect plus the value of consistency and tapering• evolution's case for aging and why Bill wants to outsmart it for individuals• Telovital as an example of telomerase activation plus limits of anecdotal results• why average telomere length in blood can rise without true telomere lengthening• how cosmetic resurfacing immune stimulation and some growth signals can backfire• peptides stem cells and exosomes through the lens of critical meta-analysis• practical steps like yoga meditation optimism anti-inflammatory diet and the ALCAT test.For more information on Dr. Bill Andrews https://sierrasci.com/If you care about lifespan, healthspan, and staying fast in the water as you get longer lived, subscribe, share this with a training partner, and leave a review so more athletes can find the show.Email us at HELLO@ChampionsMojo.com. Opinions discussed are not medical advice, please seek a medical professional for your own health concerns.You can learn more about the Host and Founder of Champions Mojo at www.KellyPalace.com

In this episode of the Epigenetics Podcast, we talked with Peter Becker from the  Biomedical Center Munich about his successful career in Epigenetics, where he discovered the chromatin remodeler ISWI and dosage compensation complex MOF. Dr. Becker shares thoughts about his postdoctoral work with Carl Wu, where he developed embryo extract systems for studying chromatin assembly and transcription. He explains how work on Drosophila extracts led to the purification of ATP-dependent remodeling factors, including ISWI-related complexes, and how these studies showed that such factors slide nucleosomes and help organize chromatin. We also cover his move to EMBL and later to Munich, where his lab expanded into dosage compensation in Drosophila. He describes work on the MSL complex targeting, MRE sequences, ROX RNA, DNA shape features, and how biochemical reconstitution was used to study how the complex recognizes the X chromosome. Finally, we discuss his later work on TIP-60 and histone acetylation, including acetylome studies, and his reflections on leadership roles at EMBL and on the use of the term epigenetics. He emphasizes that epigenetics should be understood as one layer among genetics, environment, and socialization, not as a replacement for genetics. References Tsukiyama, T., Becker, P. B., & Wu, C. (1994). ATP-dependent nucleosome disruption at a heat-shock promoter mediated by binding of GAGA transcription factor. Nature, 367(6463), 525–532. https://doi.org/10.1038/367525a0 Varga-Weisz, P. D., Wilm, M., Bonte, E., Dumas, K., Mann, M., & Becker, P. B. (1997). Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II. Nature, 388(6642), 598–602. https://doi.org/10.1038/41587 Corona, D. F., Längst, G., Clapier, C. R., Bonte, E. J., Ferrari, S., Tamkun, J. W., & Becker, P. B. (1999). ISWI is an ATP-dependent nucleosome remodeling factor. Molecular cell, 3(2), 239–245. https://doi.org/10.1016/s1097-2765(00)80314-7 Akhtar, A., & Becker, P. B. (2000). Activation of transcription through histone H4 acetylation by MOF, an acetyltransferase essential for dosage compensation in Drosophila. Molecular cell, 5(2), 367–375. https://doi.org/10.1016/s1097-2765(00)80431-1 Akhtar, A., Zink, D., & Becker, P. B. (2000). Chromodomains are protein-RNA interaction modules. Nature, 407(6802), 405–409. https://doi.org/10.1038/35030169 Villa, R., Schauer, T., Smialowski, P., Straub, T., & Becker, P. B. (2016). PionX sites mark the X chromosome for dosage compensation. Nature, 537(7619), 244–248. https://doi.org/10.1038/nature19338 Related Episodes Dosage Compensation in Drosophila (Asifa Akhtar) DNase Hypersensitive Sites and Chromatin Remodeling Enzymes (Carl Wu) The Mechanism of ATP-dependent Remodelers and HP1 Gene Silencing (Geeta Narlikar) Regulation of Chromatin Organization by Histone Chaperones (Geneviève Almouzni) Contact Epigenetics Podcast on Mastodon Epigenetics Podcast on Bluesky Dr. Stefan Dillinger on LinkedIn Active Motif on LinkedIn Active Motif on Bluesky Email: podcast@activemotif.com

BUFFALO, NY — June 3, 2026 — A new #research paper was #published in Volume 18 of Aging-US on May 15, 2026, titled “Extracellular vesicles released by senescent myoblasts affect recipient cells via miRNA-target interactions.” The study was led by first author Michael Kamal from the Department of Kinesiology at McMaster University and corresponding author Gianni Parise from the same university. As people age, skeletal muscle gradually loses strength, size, and regenerative capacity. Scientists have increasingly linked these changes to cellular senescence—a state in which damaged cells permanently stop dividing but remain metabolically active. These senescent cells release a complex mixture of signaling molecules known as the senescence-associated secretory phenotype (SASP), which can influence neighboring cells and contribute to tissue dysfunction. In this study, the researchers investigated whether extracellular vesicles (EVs)—tiny membrane-bound particles released by cells—play a role in this process. Specifically, they examined EVs released by senescent muscle precursor cells, known as myoblasts, and analyzed the microRNAs (miRNAs) carried within these vesicles. The team found that senescent myoblasts released factors that impaired normal muscle cell development. When healthy muscle cells were exposed to signals from senescent cells, the resulting muscle fibers became significantly smaller and displayed increased expression of genes associated with cellular stress and senescence. Further analysis revealed that EVs released by senescent myoblasts carried a distinct set of miRNAs. The researchers identified 22 significantly altered miRNAs, including several previously linked to cellular senescence, such as miR-34a, miR-34b, miR-34c, and miR-22. The study also identified miR-301a-3p as a potentially novel senescence-associated miRNA. Full press release - https://aging-us.net/2026/06/03/senescent-muscle-cells-send-molecular-messages-that-may-contribute-to-age-related-muscle-decline/ DOI - https://doi.org/10.18632/aging.206379 Corresponding author - Gianni Parise - pariseg@mcmaster.ca Abstract video - https://www.youtube.com/watch?v=HKBbraYg8ew Sign up for free Altmetric alerts about this article - https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.206379 Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts Keywords - aging, cellular senescence, extracellular vesicles, myoblasts, miRNA, multi-omics To learn more about the journal, please visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 X - https://twitter.com/AgingJrnl Facebook - https://www.facebook.com/AgingUS/ Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

Do you know how the different therapies act in hemophilia A? Credit available for this activity expires: 05/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/molecular-nuances-hemostasis-differentiating-fviii-and-non-2026a1000hk2?ecd=bdc_podcast_libsyn_mscpedu

Ross Halls caught up with Ipswich Town legend Tony Mowbray to discuss his time at Portman Road and journey in football in our Kings of Anglia podcast special.Tony spoke about a range of memories, including his early days in football, the nickname 'Mogga', playing for his boyhood club in Middlesbrough and a life-changing moment at Celtic.He chats about George Burley persuading him to sign for Ipswich, his goal at Wembley and overall time in Suffolk as a player and coach.The duo also discuss his bowel cancer recovery, getting back into management and if he was ever close to becoming Town manager.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Alex Jones to discuss the latest Ipswich Town transfer rumours.The boys start with two foreign names - Real Betis' Nelson Deossa and OH Leuven's Roggerio Nyakossi, who have both been linked with moves to Portman Road.Then it's onto the stars, following rumours surrounding Solly March, Ethan Nwaneri and Harvey Elliott, who could be on the move this summer.There's also chat about whether the Blues should target soon-to-be free agent Jamie Vardy in their search for an experienced no.9 in the Premier League.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Mark Heath is back with Ross Halls and Alex Jones to discuss all things Ipswich Town on the latest KOA podcast.We start with a look at the latest transfer rumour sexy stuff before diving into a mountain of Mailbag from across all social media platforms.We tackle questions as diverse as how many strikers Town need to sign, foreign recruitment and potential competition for Leif Davis to our favourite ice-creams, dream pod record locations and if we'd rather fight a kangaroo or a badger.Plus will Town stay up, who wins in a Premier League nickname Battle Royale - and AJ has a message for his haters.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

In today's episode, we spoke with Anthony Chi, MD, a staff pathologist; Monica Peravali, MD, a medical oncologist; and Archana Jadhav, MD, a medical oncologist, all faculty at the Mid-Atlantic Permanente Medical Group in Maryland. In our exclusive interview, Drs Chi, Peravali, and Jadhav discussed the practical advantages and clinical implications of implementing in-house next-generation sequencing (NGS) testing for patients with non–small cell lung cancer (NSCLC). The conversation focused on how internal molecular testing platforms can improve turnaround times, optimize tissue stewardship, reduce costs, and enhance quality control across the diagnostic and treatment continuums.Chi explained that performing NGS internally eliminates delays associated with specimen transportation and external laboratory accessioning, significantly shortening turnaround times. He also highlighted Kaiser Permanente's decision to implement a molecular platform distinct from those commonly used by outside vendors, allowing for reduced tissue input requirements and faster processing times. According to Chi, internal testing also gives pathology teams greater oversight of specimen use, enabling more strategic tissue conservation for future immunohistochemical (IHC) staining, repeat molecular analyses, or additional biomarker testing.The panel emphasized the importance of close coordination between pathology and oncology teams in maximizing tissue adequacy, particularly in small biopsies and cytology specimens. Chi described educational initiatives implemented within pathology departments to encourage judicious use of IHC stains and preserve tissue for downstream molecular testing. He also outlined specimen-handling workflows in which tissue is divided into separate cassettes to prioritize molecular analysis and still supporting diagnostic evaluation.Jadhav discussed the oncologist's role in ensuring adequate tissue acquisition, emphasizing proactive communication with pathologists and interventional radiologists. She noted that when clinicians anticipate limited tissue yield, such as in pleural fluid cytology specimens, they often promptly arrange additional biopsies to avoid delays in treatment initiation and ensure comprehensive genomic profiling can be completed efficiently.The discussion also addressed optimal timing for comprehensive genomic profiling in NSCLC. Peravali explained that Kaiser Permanente routinely performs NGS across all disease stages, including early-stage disease, due to increasing use of neoadjuvant chemoimmunotherapy approaches and the need to identify actionable biomarkers that may influence treatment selection. Although in-house testing serves as the primary platform, she noted that send-out testing remains important in select situations, including cancers of unknown primary origin, clinical trial enrollment, and discordant or clinically suspicious cases requiring additional confirmation.As molecular reports become increasingly complex, the panel highlighted the importance of interpreting co-mutations, variants of unknown significance, and emerging biomarkers within a broader clinical context. Peravali explained that although variants without current therapeutic relevance may not immediately affect treatment decisions, repeat biopsies and serial NGS at disease progression can reveal newly actionable alterations as therapeutic options evolve.Chi further emphasized the growing importance of newly approved biomarkers, including HER2 and c-MET alterations, in NSCLC. He described how pathology teams actively monitor FDA approvals and National Comprehensive Cancer Network (NCCN) guideline updates to identify new therapeutic opportunities for previously profiled patients. In some cases, archived tumor specimens are revisited for additional IHC testing when emerging therapies become clinically relevant.The conversation also highlighted the value of multidisciplinary collaboration and tumor board discussions in complex diagnostic scenarios. The speakers described how integrated molecular analysis can help distinguish separate primary lung tumors from metastatic disease, resolve diagnostically challenging cases involving uncommon metastatic presentations, and support more confident staging and treatment decisions.Finally, the panel underscored that successful implementation of precision oncology workflows depends on seamless collaboration among pulmonologists, pathologists, oncologists, interventional radiologists, and molecular laboratories. Early test ordering, centralized communication systems, and multidisciplinary case review were identified as key components of efficient, patient-centered care that can accelerate diagnosis and improve treatment planning for patients with lung cancer.

In today's episode, we spoke with Jacob Sands, MD. Dr Sands is the associate chief of the Lowe Center for Thoracic Oncology, Oncology Medical Director of the International Patient Center, and physician at Dana-Farber Cancer Institute, as well as an assistant professor at Harvard Medical School in Boston, Massachusetts. In our exclusive interview, Dr Sands discussed the rapidly evolving treatment landscape for small cell lung cancer (SCLC), emphasizing both the progress made with immunotherapy and the ongoing challenges associated with this aggressive disease. He noted that outcomes now vary widely, with some patients experiencing long-term durable disease control following checkpoint inhibitor therapy, while others continue to have limited benefit from currently available treatments.A major focus of the discussion centered on tarlatamab-dlle (Imdelltra), the DLL3-targeting bispecific T-cell engager approved for relapsed SCLC. Sands described tarlatamab as a “new paradigm” therapy, highlighting results from the phase 3 DeLLphi-304 trial (NCT05740566) showing superiority in progression-free survival, overall survival, symptom improvement, and toxicity outcomes vs chemotherapy in the second-line setting. He also reviewed the evolution of DLL3 as a therapeutic target, explaining how earlier efforts with rovalpituzumab tesirine (Rova-T) helped establish the foundation for newer, more effective DLL3-directed approaches. The conversation also explored the growing role of molecular subtyping in SCLC, including emerging data involving ASCL1, NEUROD1, and POU2F3 transcription factor subsets. Although Sands cautioned that these findings remain investigational, he noted that subtype-driven treatment selection may eventually help personalize therapy in SCLC.Sands also addressed real-world experience with tarlatamab, including higher observed rates of cytokine release syndrome and neurologic toxicities among patients who would not have qualified for clinical trials. Despite these risks, he emphasized that many heavily pretreated patients with poor performance status or brain metastases have still achieved meaningful and durable clinical benefit.Finally, the discussion covered recent updates to National Comprehensive Cancer Network guidelines, including the establishment of tarlatamab as a preferred second-line standard of care regardless of chemotherapy-free interval. Looking ahead, Sands highlighted the growing pipeline of investigational therapies in SCLC, including CAR T-cell therapies, antibody-drug conjugates, radioligand therapies, and additional T-cell engagers, stressing the importance of clinical trial referral and collaboration between academic and community oncology centers.

Stuart Watson sat down with Conor Chaplin in the wake of the announcement of his departure from Ipswich Town.The duo discuss how he's feeling, look back over some his favourite moments and what could be next for the modern day club legend. Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Alex Jones to discuss the transfer chat around Ipswich Town in our new weekly round-up. The boys discuss the truth behind links to Millwall winger Femi Azeez before moving on to Valencia's interest in Dan Neil and transfer comments from ex-Blue Troy Parrott.There's also chat around what's next for Conor Chaplin, with Championship interest following his Portman Road departure, while youngster Leon Ayinde gets a good League One move.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

In this episode, host Sylvie Legere sits down with Shira Kupperman Boehler and Dr. Kim Sandler to discuss the vital topic of early lung cancer detection. Having been diagnosed after a precautionary scan, non-smoker Shira shares her harrowing journey and advocates for change in diagnostic guidelines. Broadcasting from Wrigley Field emphasizes the importance of transforming how lung cancer is diagnosed, and how it is perceived by the medical community and public. Their conversation dives into the shortcomings of current screening guidelines and the urgent need for change to save more lives, especially for those who don't fall within the traditional risk categories. Through personal narratives and professional expertise, Dr. Sandler and Shira Kupperman Boehler share a holistic approach to detect lung cancer early by employing cutting-edge technologies and personalized medicine.  Act after listening: 1. Find out if you qualify for a free scan. If you're between 50–80 with a significant smoking history, you may be eligible for an annual low-dose CT scan — covered by Medicare and most private insurance. (Link in Resources below) 2. Ask your doctor even if you don't qualify. The current guidelines don't cover never-smokers — but that doesn't mean your risk is zero. At your next appointment, ask: "What is my personal lung cancer risk, and should I be screened?" Don't wait for symptoms. 3. Add your voice to change the guidelines. The screening criteria need to be expanded. Visit the Cancer Doesn't Care Foundation to learn how to advocate for policy change — and to share your own story if you have one. 4. Share this episode. The person who needs to hear this probably thinks they're fine. Send it to someone you love.  Guest Bios Shira Kupperman Boehler is a finance professional and health advocate with degrees in Molecular and Cell Biology from the University of California, Berkeley, and an MBA from New York University's Stern School of Business. A lifelong athlete and mother of four, she now channels her experience into raising awareness about early lung cancer detection and advancing conversations around prevention and policy. Shira and her family live in Tennessee, where she juggles life from her minivan with a coffee in one hand and a carpool schedule in the other.   Dr. Kim Lori Sandler -  Kim is a Nashville native who completed her undergraduate education at Emory University and both medical school and residency at Vanderbilt University. She trained as a cardiothoracic radiologist and is currently a Professor of Radiology and Radiological Sciences at Vanderbilt University Medical Center.  Dr. Kim is a clinician-scientist and serves as the Director of the Vanderbilt Lung Screening Program. She is a women's health advocate who is working to leverage the success of screening for breast cancer to improve enrollment of women in lung screening.  Her research also focuses on improving lung cancer risk prediction and early detection with the incorporation of machine learning and both imaging and blood-based biomarkers.  Resources & Links Visit Shira Kupperman Boehler's Website Order Shira's book ‘Cancer Doesn't Care' and learn more about Shira Boehler's campaign to change the national lung screening guidelines Take The American Lung Association's "Saved By The Scan" quiz Take the Lung Cancer Basics & Screening Eligibility Quiz from LUNGevity 

Mark Heath is joined by Stuart Watson and Alex Jones for the latest KOA pod.The boys chat about the extraordinary Southampton Spygate story, whether the punishment fits the crime and potential future implications.Then it's on to Conor Chaplin's impending departure, Stu's exclusive chat with him and Town's Band of Brothers Mount Rushmore. We finish with a spot of sexy stuff, plus a look at the final weekend of the Premier League and some TV recommendations.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

ReferencesFront. Endocrinol., 2019. 02 July Sec. Molecular and Structural Endocrinology Volume 10 -J Cell Physiol. 2026 May;241(5):e70190Thromb Haemost.2009 Sep;102(3):544–554.Guerra, DJ. 2026.Unpublished LecturesCahn and Heusen. 1957. All The Way Frank Sinatrahttps://open.spotify.com/track/7fanCwOck16J9MPJ3SR39P?si=df1d1051137648f4Dvorak, A. 1983. American String Quintet 3. E Flat Major OP.97https://music.youtube.com/watch?v=cip5TJ7H4jg&si=kOTQNlmy93LDJNvL

What if you could know which batteries are worth building before you actually build them? Taylor and Andrew sit down with Dr. Qichao Hu, founder of SES AI, to explore how artificial intelligence is reshaping battery discovery and his experience in the field. From his decision to ditch solid state electrolytes and double down on liquid, to building a suite of simulation tools that map molecules all the way up to full cell performance. Dr. Hu lays out how SES went from lithium metal battery startup to offering their hard-won design tools as a platform for the rest of the industry. This episode of the Materialism Podcast is sponsored by SES AI. To learn more about their tools and how they can benefit you check out their website. [LINK] This episode of the Materialism Podcast is sponsored by Momentum Transfer. Visit their website for more details about their measurement services. [LINK] The Materialism Podcast is sponsored by Materials Today, an Elsevier community dedicated to the creation and sharing of materials science knowledge and experience through their peer-reviewed journals, academic conferences, educational webinars, and more. [LINK] Thanks to Kolobyte and Alphabot for letting us use their music in the show! If you have questions or feedback please send us emails at materialism.podcast@gmail.com or connect with us on social media: Instagram, Twitter. Materialism Team: Taylor Sparks, Andrew Falkowski, & Jared Duffy.

Alex Jones and Ross Halls discuss the transfer chat around Ipswich Town in our new weekly round-up. The duo bring you up to speed on all the latest links, starting with goalkeeper Aro Muric, who is currently on loan at Italian side Sassuolo, but looks set for a permanent move elsewhere.They also delve into rumours surrounding a versatile Ligue 1 defender, a Dutch striker, an in-form ex-Blue, and much more.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Molecular biology is often introduced through the central dogma: DNA makes RNA, and RNA makes protein. But biology is rarely that simple. In this episode, Sanjay discusses how discoveries such as non-coding RNAs have expanded our understanding of how genetic information works, and how he uses computational approaches to investigate the functions and structures of these mysterious molecules. Tune in to hear about the frontier of RNA biology, the shift from PhD to postdoc, and Sanjay's unique journey from the social sciences into biophysics. Hosted by Matthew Vaughan and Hannah Stuwe.

El brote de hantavirus en el crucero MV Hondius ha vuelto a poner de actualidad la famosa PCR, la Reacción en Cadena de la Polimerasa, una técnica de biología molecular empleada en el diagnóstico de enfermedades infecciosas y en investigación genética. En "Más cerca" (Radio 5) hemos hablado de su descubrimiento y aplicaciones con José Manuel Bautista, catedrático de Bioquímica y Biología Molecular en la UCM. Escuchar audio

Denise M O'Sullivan, Gerwyn M Jones, Manca Zolnir-Dovc, Richard Phillips, Rejoice Arthur, Bariki Mtafya, Daniel Adon Mapamba, Daniela Maria Cirillo, Ewa Augustynowicz-Kopeć, Mei Mei Ho, Belinda Dagg, Sven O Friedrich, Francesca Colavita, Antonella Vulcano, Prince Asare, Dorothy Yeboah-Manu, Timothy D McHugh, Jim F Huggett. Methods to Improve Confidence in the Accuracy of Molecular Testing for Multidrug-Resistant Tuberculosis. Clinical Chemistry, Volume 72, Issue 3, March 2026, Pages 390–397. https://doi.org/10.1093/clinchem/hvaf178

Mark Heath is joined by Stuart Watson, Ross Halls and Alex Jones to wrap up Ipswich Town's rollercoaster promotion season and dish out some awards.We look back at our pre-season pics too - some absolute honkers - and decide things like MVP, unsung hero, surprise package, best moment and more.We all dish out some special awards - look out for Rossi's gong - and Mark has reason for celebration too.Plus we reflect on Fabio Wardley's epic title fight with Daniel Dubois and Natasha Thomas' decade at the Blues.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Ross Halls is joined by Tom Cann to talk all things Ipswich Town Women after the news of a shock departure and full retained list announced.The duo discuss legendary striker Natasha Thomas leaving after more than a decade at the club, and review the full list of players that are leaving.They also chat about David Wright being appointed the permanent manager and look back at the Tractor Girls first season in the WSL 2.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

Tu cuerpo podría tener células de tu mamá, literalmente; desde antes de nacer y durante toda tu vida. Hoy vamos a hablar del microquimerismo fetal con Iván Martínez-Duncker, especialista en Biología Molecular por el Instituto Pasteur de Francia, un fenómeno donde células de la madre y del bebé se intercambian durante el embarazo y pueden quedarse alojadas durante décadas en órganos como el cerebro, el corazón o la piel.

In this episode of Status Check with Spivey, Mike has a conversation with Vincent Sheu, an attorney and AI startup founder with a JD and a Master's in Computer Science from Stanford (in addition to degrees in Statistics, Molecular and Cell Biology, and Bioengineering).Mike and Vincent discuss how he uses AI in his legal work today (19:20, 22:20), how he expects to be using AI in legal work in the future (37:23), how important his human contributions are vs. the contributions of AI (25:32), whether AI will be able to learn EQ (27:12), the sorts of AI tooling skills that employers are (and will be) looking for (29:19, 42:45) and how they screen for those skills (33:39), the benefits of using AI for legal work as well as the risks (24:04, 31:21, 44:23), how the next generation of lawyers will be advantaged and disadvantaged in the new landscape of legal practice (30:03), whether Vincent would hire a new lawyer who was brilliant and likable but has no familiarity with AI (32:52), Vincent's recruiting process out of law school (14:03) and what his hours looked like in biglaw vs. as an in-house general counsel (19:36), how Vincent went 23 for 25 during his law school admissions cycle as a “super splitter” (3:32), and more.Near the beginning of the episode, Mike and Vincent chat about a viral video from 2014 in which Vincent rapidly completed a Rubik's Cube at a college basketball game. While the original video is now private, you can find the referenced SportsCenter article here.Mike also mentions the recent case of a defendant attempting to use an AI avatar to make their opening argument in court. You can find that video here.You can listen and subscribe to Status Check with Spivey on ⁠⁠Apple Podcasts⁠⁠, ⁠⁠Spotify⁠⁠, and ⁠⁠YouTube⁠⁠. You can read a full transcript of this episode with timestamps here.

Mark Heath is joined by Stuart Watson and Alex Jones to celebrate Ipswich Town being promoted back to the Premier League and reflect on another memorable day at Portman Road.The boys chat about Town sweeping QPR aside, consider how this season has been different to the last promotion and take you behind the scenes of the pitch party.There's discussion about Wes Burns' future too, plus debate around potentially signing Jens Cajuste, the Cedric Kipre deal and a potential summer move for Liam Delap.We tackle the thorny issue of a probable Kieran McKenna saga 2.0, plus share our favourite memories from the season.Plus Stu reveals what is what like being on the promotion bus yesterday.Kings of Anglia is sponsored Molecular! Get 10% OFF with promo code KOA10 at https://www.molecular-uk.com/Subscribe on our website to watch the video version of the podcast - https://www.eadt.co.uk/subscribe/You can shop the KOA range here - (kings-of-anglia.myspreadshop.co.uk) 

In this episode, we dive into new research findings on the prevalence and biological impact of REV and LPDV in wild turkeys.    Resources: Adcock, K. G., et al. (2024). Lymphoproliferative disease virus and reticuloendotheliosis virus detection and disease in wild turkeys (Meleagris gallopavo). The Journal of Wildlife Diseases, 60(1), 139-150. Cox, F., et al. (2022). Molecular surveillance for lymphoproliferative disease virus and reticuloendotheliosis virus in Rio Grande wild turkeys (Meleagris gallopavo intermedia) in Texas, USA. The Journal of Wildlife Diseases, 58(4), 909-913. Edge, A. et al. (2026). Regional Pathogen Surveillance of Free-Ranging Wild Turkeys (Meleagris gallopavo) in North Carolina, USA. The Journal of Wildlife Diseases, 62(1), 87-100. Goodwin, C. C., et al. (2025). Current understanding of lymphoproliferative disease virus in wild turkeys. Wildlife Society Bulletin, 49, e1644. Haynes, E., et al. (2024). Health assessment of adult male Eastern wild turkeys (Meleagris gallopavo silvestris) from Western Kentucky, USA. The Journal of Wildlife Diseases, 60(3), 660-669. Ingram, D. R., et al. (2015). Serologic survey of wild turkeys (Meleagris gallopavo) and evidence of exposure to avian encephalomyelitis virus in Georgia and Florida, USA. The Journal of Wildlife Diseases, 51(2), 374-379. Koch, R. W., et al. (2026). Risk factors and coinfection dynamics of pathogens in wild turkeys (Meleagris gallopavo) from Pennsylvania, USA. Ecology and Evolution, 16(2), e73079. Lashley, M. A., et al. (2025). Decreased female survival may help explain wild turkey population decline. Wildlife Society Bulletin, e1642. MacDonald, A. M., et al. (2019). Lymphoproliferative disease virus in wild turkeys (Meleagris gallopavo) from Manitoba and Quebec, Canada. Avian Diseases, 63(3), 506-510. Ostrander, K. N., et al. (2025). Histomonosis and Lymphoproliferative Disease Virus in Male Wild Turkeys (Meleagris gallopavo) in Alabama, USA. Journal of Wildlife Diseases. Shea, S. A., et al. (2026). Retroviral Infections Affect Survival and Clutch Size of Female Wild Turkeys. Ecology and Evolution, 16(4), e73383. Stewart, B., et al. (2019). Survey of reticuloendotheliosis virus in wild turkeys (Meleagris gallopavo) in Texas, USA. The Journal of Wildlife Diseases, 55(3), 689-693.   Our lab is primarily funded by donations. If you would like to help support our work, please donate here: http://UFgive.to/UFGameLab   We've launched our second online wild turkey course  ! Enroll in  Wild Turkey Manager: Biology, History & Habitat to learn about the principal biology, mating, behavior, food selection, human dimensions, hunter interactions, and historical context of wild turkeys. This course is accredited by the Society of American Foresters as a Category 2 course worth 7 Continuing Forestry Education credits. Participants can also earn up to 5 CEUs in Category I of The Wildlife Society's Certified Wildlife Biologist Program. Enroll now: https://tinyurl.com/WildTurkeyManagerBio   Be sure to check out our first comprehensive online wild turkey course featuring experts across multiple institutions that specialize in habitat management and population management for wild turkeys. Earn up to 20.5 CFE hours! Enroll Now!    Dr. Marcus Lashley @DrDisturbance, Publications Dr. Will Gulsby @dr_will_gulsby, Publications Turkeys for Tomorrow @turkeysfortomorrow  UF Game Lab @ufgamelab, YouTube   Want to help wild turkey conservation? Please take our quick survey to take part in our research!   Do you have a topic you'd like us to cover? Leave us a review or send us an email at wildturkeyscience@gmail.com!   Watch these podcasts on YouTube   Please help us by taking our (quick) listener survey - Thank you!    Check out the DrDisturbance YouTube channel! DrDisturbance YouTube   Want to help support the podcast? Our friends at Grounded Brand have an option to donate directly to Wild Turkey Science at checkout. Thank you in advance for your support!   Leave a podcast rating for a chance to win free gear!   This podcast is made possible by Turkeys for Tomorrow, a grassroots organization dedicated to the wild turkey. To learn more about TFT, go to turkeysfortomorrow.org.    Music by Artlist.io Produced & edited by Charlotte Nowak

In this episode, we dive into new research findings on the prevalence and biological impact of REV and LPDV in wild turkeys.    Resources: Adcock, K. G., et al. (2024). Lymphoproliferative disease virus and reticuloendotheliosis virus detection and disease in wild turkeys (Meleagris gallopavo). The Journal of Wildlife Diseases, 60(1), 139-150. Cox, F., et al. (2022). Molecular surveillance for lymphoproliferative disease virus and reticuloendotheliosis virus in Rio Grande wild turkeys (Meleagris gallopavo intermedia) in Texas, USA. The Journal of Wildlife Diseases, 58(4), 909-913. Edge, A. et al. (2026). Regional Pathogen Surveillance of Free-Ranging Wild Turkeys (Meleagris gallopavo) in North Carolina, USA. The Journal of Wildlife Diseases, 62(1), 87-100. Goodwin, C. C., et al. (2025). Current understanding of lymphoproliferative disease virus in wild turkeys. Wildlife Society Bulletin, 49, e1644. Haynes, E., et al. (2024). Health assessment of adult male Eastern wild turkeys (Meleagris gallopavo silvestris) from Western Kentucky, USA. The Journal of Wildlife Diseases, 60(3), 660-669. Ingram, D. R., et al. (2015). Serologic survey of wild turkeys (Meleagris gallopavo) and evidence of exposure to avian encephalomyelitis virus in Georgia and Florida, USA. The Journal of Wildlife Diseases, 51(2), 374-379. Koch, R. W., et al. (2026). Risk factors and coinfection dynamics of pathogens in wild turkeys (Meleagris gallopavo) from Pennsylvania, USA. Ecology and Evolution, 16(2), e73079. Lashley, M. A., et al. (2025). Decreased female survival may help explain wild turkey population decline. Wildlife Society Bulletin, e1642. MacDonald, A. M., et al. (2019). Lymphoproliferative disease virus in wild turkeys (Meleagris gallopavo) from Manitoba and Quebec, Canada. Avian Diseases, 63(3), 506-510. Ostrander, K. N., et al. (2025). Histomonosis and Lymphoproliferative Disease Virus in Male Wild Turkeys (Meleagris gallopavo) in Alabama, USA. Journal of Wildlife Diseases. Shea, S. A., et al. (2026). Retroviral Infections Affect Survival and Clutch Size of Female Wild Turkeys. Ecology and Evolution, 16(4), e73383. Stewart, B., et al. (2019). Survey of reticuloendotheliosis virus in wild turkeys (Meleagris gallopavo) in Texas, USA. The Journal of Wildlife Diseases, 55(3), 689-693.   Our lab is primarily funded by donations. If you would like to help support our work, please donate here: http://UFgive.to/UFGameLab   We've launched our second online wild turkey course  ! Enroll in  Wild Turkey Manager: Biology, History & Habitat to learn about the principal biology, mating, behavior, food selection, human dimensions, hunter interactions, and historical context of wild turkeys. This course is accredited by the Society of American Foresters as a Category 2 course worth 7 Continuing Forestry Education credits. Participants can also earn up to 5 CEUs in Category I of The Wildlife Society's Certified Wildlife Biologist Program. Enroll now: https://tinyurl.com/WildTurkeyManagerBio   Be sure to check out our first comprehensive online wild turkey course featuring experts across multiple institutions that specialize in habitat management and population management for wild turkeys. Earn up to 20.5 CFE hours! Enroll Now!    Dr. Marcus Lashley @DrDisturbance, Publications Dr. Will Gulsby @dr_will_gulsby, Publications Turkeys for Tomorrow @turkeysfortomorrow  UF Game Lab @ufgamelab, YouTube   Want to help wild turkey conservation? Please take our quick survey to take part in our research!   Do you have a topic you'd like us to cover? Leave us a review or send us an email at wildturkeyscience@gmail.com!   Watch these podcasts on YouTube   Please help us by taking our (quick) listener survey - Thank you!    Check out the DrDisturbance YouTube channel! DrDisturbance YouTube   Want to help support the podcast? Our friends at Grounded Brand have an option to donate directly to Wild Turkey Science at checkout. Thank you in advance for your support!   Leave a podcast rating for a chance to win free gear!   This podcast is made possible by Turkeys for Tomorrow, a grassroots organization dedicated to the wild turkey. To learn more about TFT, go to turkeysfortomorrow.org.    Music by Artlist.io Produced & edited by Charlotte Nowak